Bausch Health Companies Inc. (BHC)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Annual

0 4B 8B 12B FY08: 757.2M FY09: 820.4M FY10: 1.2B FY11: 2.4B FY12: 3.5B FY13: 5.8B FY14: 8.2B FY15: 10.4B FY16: 9.7B FY17: 8.7B FY18: 8.4B FY19: 8.6B FY20: 8B FY21: 8.4B FY22: 8.1B FY23: 8.8B FY24: 9.6B FY25: 10.3B FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Gross Profit Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income Annual

-2.7B -1.8B -900M 0 900M 1.8B 2.7B FY08: 124.1M FY09: 181.2M FY10: -110.1M FY11: 300M FY12: 79.7M FY13: -409.5M FY14: 2B FY15: 1.5B FY16: -566M FY17: 102M FY18: -2.4B FY19: -203M FY20: 676M FY21: 450M FY22: 454M FY23: 963M FY24: 1.5B FY25: 1.8B FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Net Income Annual

-4.5B -3B -1.5B 0 1.5B 3B 4.5B FY08: 199.9M FY09: 406.6M FY10: 366.7M FY11: 159.6M FY12: -116M FY13: -863.6M FY14: 880M FY15: -288M FY16: -2.4B FY17: 2.4B FY18: -4.1B FY19: -1.8B FY20: -560M FY21: -948M FY22: -225M FY23: -592M FY24: -46M FY25: 157M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Cost of Revenue Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Annual

-800M 0 800M 1.6B 2.4B FY08: 204.3M FY09: 360.9M FY10: 263.2M FY11: 640.5M FY12: 656.6M FY13: 1B FY14: 2.3B FY15: 2.3B FY16: 2.1B FY17: 2.3B FY18: 1.5B FY19: 1.5B FY20: 1.1B FY21: 1.4B FY22: -728M FY23: 1B FY24: 1.6B FY25: 1.4B FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Free Cash Flow Annual

-1.6B -800M 0 800M 1.6B 2.4B FY08: 182.3M FY09: 353.5M FY10: 246.4M FY11: 582M FY12: 549M FY13: 926.7M FY14: 2B FY15: 2B FY16: 1.9B FY17: 2.1B FY18: 1.3B FY19: 1.2B FY20: 809M FY21: 1.2B FY22: -946M FY23: 817M FY24: 1.3B FY25: 1B FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 150M 300M 450M FY08: 159.7M FY09: 158.5M FY10: 195.8M FY11: 326.1M FY12: 305.4M FY13: 321M FY14: 341.5M FY15: 342.7M FY16: 347.3M FY17: 351.8M FY18: 351.3M FY19: 352.1M FY20: 355M FY21: 358.9M FY22: 362M FY23: 364.9M FY24: 368M FY25: 375M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-15.00 -10.00 -5.00 0.00 5.00 10.00 15.00 Q4 '09: 1.11 Q1 '10: 0.84 Q2 '10: 0.90 Q3 '10: -0.62 Q4 '10: -1.03 Q1 '11: -0.99 Q2 '13: -0.33 Q3 '13: -3.27 Q4 '13: -2.70 Q1 '14: -2.68 Q2 '14: -2.34 Q3 '14: 1.39 Q4 '14: 2.61 Q1 '15: 2.96 Q2 '15: 2.44 Q3 '15: 1.77 Q4 '15: -0.85 Q1 '16: -2.21 Q2 '16: -2.94 Q3 '16: -6.57 Q4 '16: -6.92 Q1 '17: -4.05 Q2 '17: -3.28 Q3 '17: 3.90 Q4 '17: 6.82 Q1 '18: -2.33 Q2 '18: -4.71 Q3 '18: -9.40 Q4 '18: -11.83 Q1 '19: -4.62 Q2 '19: -2.62 Q3 '19: -1.76 Q4 '19: -5.09 Q1 '20: -5.37 Q2 '20: -5.80 Q3 '20: -5.46 Q4 '20: -1.58 Q1 '21: -2.86 Q2 '21: -3.60 Q3 '21: -3.28 Q4 '21: -2.64 Q1 '22: -1.12 Q2 '22: 0.14 Q3 '22: 0.72 Q4 '22: -0.62 Q1 '23: -0.98 Q2 '23: -0.51 Q3 '23: -2.64 Q4 '23: -1.61 Q1 '24: -1.23 Q2 '24: -1.27 Q3 '24: -0.47 Q4 '24: -0.13 Q1 '25: -0.12 Q2 '25: 0.25 Q3 '25: 0.96 Q4 '25: 0.42 Q1 '26: -3.24 Q2 '26: -2.96 Q2 '10 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.